In truth wouldn't it make more sense if everyone got the same price that is profitable for the company but doesn't rip off US customers?It depends on what your definition of fair profit is. As reasonably new drugs are protected from competition by patents, then, in theory, the sky is the limit for profits. Any "big gummit" national health program that uses it's monopoly power to negotiate prices for all the residents of it's country to counterbalance the drug maker's monopoly over supply is thus spun as evil.The US media is full of industry propaganda about the evil socialist governments forcing us hard working USians to subsidize their drug supply. To hear them tell it, there are no drug companies outside of the US, because of oppressive socialist government policies...so, I guess AstraZeneca, Novartis and Sanofi are products of a deranged imagination.Sniveling about the "safety" of USian patients is more anti-importation propaganda. As soon as the patents run out and compounds fall into generic territory, no one seems to care about product quality and safety.Ranbaxy got USFDA nod with no or fraudulent data: Whistleblower Dinesh ThakurPointing out how test results were allegedly manipulated, he said: "When you find a blood sample rework for one patient copied 23 times because there are 24 patients needed to prove bioequivalence, that's not an error."http://articles.economictimes.indiatimes.com/2013-11-07/news...Ranbaxy whistleblower reveals how he exposed massive pharmaceutical fraudin 2011, while one arm of the FDA was investigating Ranbaxy for serious criminal violations, another arm of the FDA was approving Ranbaxy for the exclusive rights to make the generic version of one of the most popular pharmaceuticals of all time: Lipitor. That decision by the FDA would earn the company a reported $600 million in the first six months. http://www.cbsnews.com/8301-505263_162-57611023/ranbaxy-whis...If this one Ranbaxy employee had not come forward, would the company have ever been investigated by the FDA?Steve
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra